Association of the NRG1 gene and schizophrenia: a meta-analysis

Molecular Psychiatry
Marcus R MunafòJonathan Flint

Abstract

We investigated the association of the NRG1 gene and schizophrenia using meta-analytic techniques, combining all published data while restricting our analysis to studies investigating the most commonly reported single marker (SNP8NRG221533). We also investigated whether ancestry (European vs East Asian) and study design (family-based vs case-control) moderated any association. We found no evidence for an association of SNP8NRG221533 with schizophrenia, and significant between-study heterogeneity, which persisted when family-based studies were combined separately. However, when haplotype-based P-values were combined, there was evidence in support of an association of NRG1 with schizophrenia, and no evidence of between-study heterogeneity. Our meta-analysis provides support for the association of NRG1 with schizophrenia, but indicates that firmly establishing the role of NRG1 gene in schizophrenia by genetic association requires much larger sample sizes than have hitherto been reported. Association analyses and replications should take place at the level of the gene, rather than at the level of SNP, haplotype, or functional variant. Meta-analysis would then be carried out on the basis of the combination of P-values.

References

Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
May 18, 2000·Human Molecular Genetics·J K MillarD J Porteous
Feb 24, 2001·Psychological Methods·R B Darlington, A F Hayes
Mar 14, 2002·Proceedings of the National Academy of Sciences of the United States of America·Hui LiuMaria Karayiorgou
May 25, 2002·Human Molecular Genetics·Kodavali V ChowdariVishwajit L Nimgaonkar
Oct 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Ilya ChumakovJohn Realson
Dec 13, 2002·American Journal of Human Genetics·Hreinn StefanssonDavid St Clair
Jun 17, 2003·Molecular Psychiatry·N M WilliamsM J Owen
Jul 23, 2003·Molecular Psychiatry·J Z YangD Zhang
Oct 29, 2003·Molecular Psychiatry·M J OwenM C O'Donovan
Nov 18, 2003·American Journal of Human Genetics·Ann Van Den BogaertSven Cichon
Dec 31, 2003·Molecular Psychiatry·N IwataN Ozaki
Jan 28, 2004·Nature Genetics·Effat S EmamianJoseph A Gogos
Jun 24, 2004·European Journal of Human Genetics : EJHG·Thomas A TrikalinosJohn P A Ioannidis
Jul 21, 2004·Molecular Psychiatry·P J Harrison, D R Weinberger
Jul 24, 2004·American Journal of Human Genetics·Benjamin M Neale, Pak C Sham
Aug 11, 2004·Molecular Psychiatry·S C BakkerR S Kahn
Aug 18, 2004·Proceedings of the National Academy of Sciences of the United States of America·Michael F EganDaniel R Weinberger
Nov 17, 2004·Molecular Psychiatry·T L PetryshenP Sklar
Jun 1, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Wulf RösslerAnita Riecher-Rössler
Jul 13, 2005·Trends in Genetics : TIG·M J OwenM C O'Donovan
Nov 9, 2005·Journal of Epidemiology·Yasuaki HayashinoTsuguya Fukui
Nov 16, 2005·American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics·Herbert M LachmanTakuya Saito

❮ Previous
Next ❯

Citations

Feb 9, 2008·Cellular and Molecular Life Sciences : CMLS·M J Wieduwilt, M M Moasser
Dec 5, 2008·European Archives of Psychiatry and Clinical Neuroscience·Andrea SchmittPeter Falkai
Oct 27, 2009·European Archives of Psychiatry and Clinical Neuroscience·Andrea SchmittFritz A Henn
Jul 18, 2009·European Archives of Psychiatry and Clinical Neuroscience·Deepak Cyril D'SouzaMohini Ranganathan
Oct 12, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Malcolm W NasonLorna W Role
Jul 10, 2012·Cerebral Cortex·Aristotle N VoineskosJames L Kennedy
May 9, 2007·Schizophrenia Bulletin·Andreas Konrad, Georg Winterer
Nov 23, 2007·Schizophrenia Bulletin·Marcus R MunafòJonathan Flint
May 2, 2008·Schizophrenia Bulletin·S Kristian HillJohn A Sweeney
May 12, 2009·Schizophrenia Bulletin·Afke F Terwisscha van ScheltingaRené S Kahn
Jun 19, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Stephan ZüchnerJean C Beckham
Feb 7, 2007·Current Opinion in Psychiatry·Lynn E DeLisi, Wolfgang Fleischhaker
Mar 12, 2008·Current Opinion in Psychiatry·Neeltje E van HarenRené S Kahn
Jun 26, 2009·Current Opinion in Psychiatry·Sibylle G Schwab, Dieter B Wildenauer
May 11, 2012·Neuro-Signals·Clare FauxJoanne M Britto
May 18, 2013·BMC Medicine·Uzoezi OzomaroCharles B Nemeroff
Dec 14, 2012·Genome Medicine·Masaki NishiokaKazuya Iwamoto
May 17, 2012·PLoS Genetics·Clara Sze-Man TangMaria-Mercè Garcia-Barceló
Jun 10, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xihui LiuLin Mei
Sep 28, 2010·Annual Review of Pharmacology and Toxicology·Hisham M Ibrahim, Carol A Tamminga
Oct 4, 2008·Proceedings of the National Academy of Sciences of the United States of America·Oh Bin KwonAndres Buonanno
May 30, 2013·Translational Psychiatry·A HatzimanolisD Avramopoulos
Sep 1, 2015·Schizophrenia Bulletin·Alexis C EdwardsAyman H Fanous
Jan 31, 2013·Schizophrenia Research·Prachi KukshalB K Thelma
Jul 6, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ina GieglingDan Rujescu
Dec 1, 2009·Journal of Neurodevelopmental Disorders·Sheryl S MoyE S Anton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.